Race Oncology reports final data from preclinical melanoma research program

Race Oncology Ltd (ASX:RAC)'s Dr Daniel Tillett speaks with Proactive's Andrew Scott after the company reported positive final results from its preclinical...

Related Keywords

Daniel Tillett ,Andrew Scott ,Race Oncology Ltd ,